Sarcomatrix Therapeutics Engages PatentVest to Strengthen IP Strategy for Lead Cardiomyopathy Program
Integrated IP intelligence, strategy, and legal execution designed to strengthen enterprise value ahead of IND RENO, NV, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- Sarcomatrix Therapeutics, Corp., a preclinical-stage biopharmaceutical …